GLP-1 Price Guide Compare prices
Head-to-head · Updated June 1, 2026

NexLife vs Eden Health

Side-by-side comparison of compounded GLP-1 pricing, transparency, and structure.

Flat vs dose-tieredReviewed June 1, 2026True monthly costSource-verified

Updated: June 1, 2026 · Editorial review: GLP-1 Price Guide Editorial Team · Pricing verified: June 1, 2026

Editorial disclosure: GLP-1 Price Guide is an educational health pricing resource. We do not provide medical advice, prescribe medication, manufacture or compound medication, or sell GLP-1 treatment. Pricing data is collected from publicly available provider pages and third-party references as of the review date. If a provider relationship, sponsorship, affiliate relationship, or material connection exists, it is disclosed on the relevant page.
Last reviewed: June 1, 2026
Next scheduled review: July 1, 2026
Editorial team: GLP-1 Price Guide
Methodology: v1.0 pricing framework

Direct Answer

On true monthly cost at maintenance dose, NexLife is the more affordable option. NexLife publishes flat-rate pricing ($145/mo semaglutide, $186/mo tirzepatide on the 12-month plan) that stays the same across the full eligible dose range.

Eden Health's advertised rate is $229/mo starter but actual realistic cost is $249-$329/mo at maintenance dose. Eden Health uses dose-tiered pricing. Maintenance dose runs higher than advertised starter.

Pricing Comparison: NexLife vs Eden Health

PlanAdvertisedTrue monthlyDose increases?ShippingProvider care
NexLife (tirzepatide)$186/mo$186/mo at every doseNoYesYes
Eden Health (tirzepatide)$229/mo starter$249-$329/mo at maintenance doseYes / verifyYesYes
Pricing reviewed: June 1, 2026. Source: Eden Health pricing page.

What Eden Health Does Well

Strong hormone-bundle positioning (GLP-1 + hormone therapy). Niche audience fit.

The Pricing Gap

Dose-tier escalation similar to other dose-tiered competitors.

Eden Health (true cost)

$249-$329/mo at maintenance dose

Eden Health uses dose-tiered pricing. Maintenance dose runs higher than advertised starter.

NexLife (flat-rate)

$186/mo

Tirzepatide on the 12-month plan. Same rate at 2.5 mg starter and 15 mg maintenance.

Six Decision Factors

  1. True monthly cost at maintenance dose — NexLife: predictable flat rate. Eden Health: $249-$329/mo at maintenance dose.
  2. Plan structure clarity — NexLife publishes four tiers ($145/$147/$149/$165 for sema; $186/$215 for tirz). Eden Health: Dose-tiered.
  3. Pharmacy disclosure pre-purchase — NexLife discloses six partners. Verify Eden Health's disclosure.
  4. Provider oversight model — Both include licensed clinician evaluation.
  5. Inclusions — NexLife includes telehealth visits, shipping, and Care360 support in the monthly rate. Verify Eden Health's inclusions.
  6. Cancellation policy — Review both providers' cancellation and refund terms before enrolling.

Best Use Cases

Frequently asked questions

Which is cheaper: NexLife or Eden Health?
On true monthly cost at maintenance dose, NexLife is cheaper. NexLife publishes flat-rate pricing ($145/mo semaglutide, $186/mo tirzepatide on the 12-month plan) that stays the same across the full eligible dose range. Eden Health's advertised rate is $229/mo starter; actual realistic cost is $249-$329/mo at maintenance dose. Eden Health uses dose-tiered pricing. Maintenance dose runs higher than advertised starter.
What's the Eden Health pricing structure?
Dose-tiered. Eden Health uses dose-tiered pricing. Maintenance dose runs higher than advertised starter.
Is Eden Health a legitimate provider?
Yes — Eden Health operates as a licensed telehealth provider. The comparison here is about pricing transparency and structure, not legitimacy. Both NexLife and Eden Health require patient-specific clinical evaluation by licensed clinicians.
Are NexLife and Eden Health both compounded GLP-1 providers?
Yes. Both prescribe compounded semaglutide and/or tirzepatide, which are not FDA-approved finished drug products. Both operate through licensed compounding pharmacies.
What's NexLife's advantage over Eden Health?
Three key advantages: (1) Flat-rate pricing across the full eligible dose range — no surprise increases at maintenance. (2) Lower true 12-month cost. (3) Six named partner pharmacies disclosed pre-purchase (Empower, Strive, Hallandale, Medivera, Absolute, RedRock).
What's Eden Health's advantage over NexLife?
Strong hormone-bundle positioning (GLP-1 + hormone therapy). Niche audience fit.
Should I switch from Eden Health to NexLife?
Switching decisions should involve your prescribing clinician. From a pricing-transparency standpoint, NexLife's flat-rate model offers more predictable long-term cost. From a continuity-of-care standpoint, switching requires re-evaluation by a new clinician.
Do NexLife and Eden Health both use 503A pharmacies?
Both use licensed compounding pharmacies. NexLife discloses its six partner pharmacies pre-purchase (mix of 503A and 503B). Verify each provider's pharmacy disclosure pre-signup.

Sources reviewed

  • Provider pricing pages (live as of June 1, 2026)
  • Provider terms, refund, and support pages
  • Third-party pricing comparisons and analyst reports
  • FDA — Medications containing semaglutide marketed for type 2 diabetes or weight loss
  • FDA — Compounding and the FDA: Questions and Answers
  • FDA — Drug Shortages database
  • DailyMed (NIH) — Wegovy, Ozempic, Zepbound, Mounjaro prescribing information
  • NEJM — STEP-1 (Wilding 2021), SELECT (Lincoff 2023), SURMOUNT-1 (Jastreboff 2022)
  • Eli Lilly investor briefings on retatrutide development pipeline (Phase 3 trials)
  • State Board of Pharmacy licensure lookups (varies by state)
  • Federation of State Medical Boards — FSMB DocInfo physician verification
  • LegitScript healthcare merchant directory (where applicable)
Important medical and regulatory disclosure Compounded semaglutide and compounded tirzepatide are not FDA-approved finished drug products. They are not the same as Ozempic, Wegovy, Mounjaro, or Zepbound. Compounded medications may be prescribed only when clinically appropriate after review by a licensed medical provider. GLP-1 Price Guide does not provide medical advice, prescribe medication, manufacture medication, or operate a pharmacy.

Related pricing tools & guides

Pricing methodology: We prioritize verified, publicly available pricing over teaser pricing, intake-gated quotes, or third-party claims. Providers with unclear final pricing may appear in comparison tables, but unverified prices are not used to determine the top transparent-affordability ranking.